Science Explorer Interactive view Map
Company · Chalfont Saint Peter · United Kingdom

Daiichi Sankyo (United Kingdom)

daiichi-sankyo.co.ukROR OpenAlex
World rank, all time
#38,529
of 42,892
Rank in United Kingdom
#2,064
of 2,253
Research works
128
▼ 6% vs 2013–17
Citations
1.6k
12.8 per fractional work
Top-10% rate
7.6%
record average 16.5%
Open access
58%
world 28%

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.37× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 4.21× its world share, 6 worksBiochemistry, Geneti…Immunology and Microbiology: 3.78× its world share, 1 worksImmunology and Micro…Pharmacology, Toxicology and Pharmaceutics: 6.28× its world share, 1 worksPharmacology, Toxico…Chemistry: 3.48× its world share, 2 worksChemistryComputer Science: 0.13× its world share, 0 worksComputer ScienceEnergy: 1.27× its world share, 0 worksEnergyEngineering: 0.36× its world share, 2 worksEngineeringEnvironmental Science: 0.06× its world share, 0 worksEnvironmental ScienceMaterials Science: 1.09× its world share, 1 worksMaterials ScienceMathematics: 1.52× its world share, 0 worksMathematicsPhysics and Astronomy: 0.09× its world share, 0 worksPhysics and AstronomyHealth Professions: 0.28× its world share, 0 worksHealth ProfessionsMedicine: 1.97× its world share, 11 worksMedicineNursing: 0.30× its world share, 0 worksNursingDecision Sciences: 2.46× its world share, 1 worksDecision SciencesEconomics, Econometrics and Finance: 4.09× its world share, 2 worksEconomics, Econometr…Psychology: 0.19× its world share, 0 worksPsychologySocial Sciences: 0.01× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 6.3×. Every wedge is a field page.

Which keywords describe research at Daiichi Sankyo (United Kingdom)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Quality of Life, Cost-effectiveness Analysis, Health Utility Measures, Chemotherapy, Guidelines, Breast Cancer, Catheter Ablation and Anticoagulant Therapy.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 19 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 19 words, with their numbers
  1. Quality of Life3▲ 6.8×6 topics
  2. Cost-effectiveness Analysis2▲ 86×1 topic
  3. Health Utility Measures2▲ 86×1 topic
  4. Chemotherapy2▲ 7.8×11 topics
  5. Breast Cancer1▲ 21×4 topics
  6. Catheter Ablation1▲ 40×2 topics
  7. Guidelines1▲ 11×4 topics
  8. Anticoagulant Therapy1▲ 37×2 topics
  9. Metastatic Breast Cancer1▲ 78×2 topics
  10. Monoclonal Antibody1▲ 86×2 topics
  11. Stroke Prevention1▲ 37×2 topics
  12. Atrial Fibrillation1▲ 44×1 topic
  13. Clinical Practice Guidelines1▲ 7.5×7 topics
  14. Risk Stratification1▲ 60×1 topic
  15. Biomarkers1▲ 5.8×8 topics
  16. Cancer1▲ 2.9×8 topics
  17. Monoclonal Antibodies1▲ 42×3 topics
  18. Biopharmaceuticals1▲ 70×3 topics
  19. Clinical Trials1▲ 5.4×4 topics

Which research topics does Daiichi Sankyo (United Kingdom) publish most on?

By volume in 2022–2025: Health Systems, Economic Evaluations, Quality of Life, Atrial Fibrillation Management and Outcomes, Protein purification and stability and Breast Cancer Treatment Studies.

Health Systems, Economic…2Health Systems, Economic Evaluations, Quality of Life: 2 fractional worksAtrial Fibrillation Management and Outcomes: 1 fractional worksProtein purification and stability: 1 fractional worksBreast Cancer Treatment Studies: 1 fractional worksAdvanced Breast Cancer Therapies: 1 fractional worksEnzyme Catalysis and Immobilization: 1 fractional worksCrystallization and Solu…1Crystallization and Solubility Studies: 1 fractional worksViral Infectious Disease…1Viral Infectious Diseases and Gene Expression in Insects: 1 fractional worksHER2/EGFR in Cancer Rese…1HER2/EGFR in Cancer Research: 1 fractional worksCAR-T cell therapy resea…0CAR-T cell therapy research: 0 fractional works
Economics and EconometricsCardiology and Cardiovascular MedicineMolecular BiologyCancer Research3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 2 works
  2. 2 Atrial Fibrillation Management and Outcomes Cardiology and Cardiovascular Medicine 1 works
  3. 3 Protein purification and stability Molecular Biology 1 works
  4. 4 Breast Cancer Treatment Studies Cancer Research 1 works
  5. 5 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 1 works
  6. 6 Enzyme Catalysis and Immobilization Molecular Biology 1 works
  7. 7 Crystallization and Solubility Studies Materials Chemistry 1 works
  8. 8 Viral Infectious Diseases and Gene Expression in Insects Molecular Biology 1 works
  9. 9 HER2/EGFR in Cancer Research Oncology 1 works
  10. 10 CAR-T cell therapy research Oncology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available58.0%not open42.0%

World: 28% of research is openly available.

with international co-authors80.8%domestic only19.2%

World: 19% is written across borders.

How has Daiichi Sankyo (United Kingdom)'s research output changed?

Output in 2018–2022 was 6% lower than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Chalfont Saint Peter

All research institutions in Chalfont Saint Peter

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.